Quick answer: GLP-1 hair loss is a known but uncommon side effect. In the trials behind the labels, hair loss affected 3.3% of adults on Wegovy 2.4 mg, 5.8% on Wegovy 7.2 mg and 4% to 5% on Zepbound, compared with about 1% on placebo, and it was far more common in women.[1][2] Both labels say it was associated with weight reduction, which points to a temporary shedding pattern called telogen effluvium rather than permanent damage.
This guide explains the label numbers, why rapid weight loss can trigger shedding, whether it grows back and what may help. For more on the drug class, see our GLP-1 basics hub, and the semaglutide and tirzepatide profiles.
How common is hair loss on GLP-1 drugs?
| Drug (dose) | Hair loss on drug | Placebo | Women vs men on drug |
|---|---|---|---|
| Wegovy 2.4 mg | 3.3% | 1% | 4% vs 0.9% |
| Wegovy 7.2 mg | 5.8% | 1.0% | 8.4% vs 0.2% |
| Zepbound 5 / 10 / 15 mg | 5% / 4% / 5% | 1% | 7.1% vs 0.5% (all doses pooled) |
| Wegovy 2.4 mg, ages 12+ | 4% | 0% | Not reported |
Sources: Wegovy and Zepbound labels.[1][2]
A few points stand out:
- It looks dose-related for semaglutide. The newer, higher 7.2 mg Wegovy dose roughly doubled the rate seen with 2.4 mg in the same trials (5.8% vs 3.3%).[1]
- Women are affected much more often. This gap shows up in both labels.[1][2]
- Few people stop the drug because of it. In Zepbound’s main trials, no one on the drug discontinued because of hair loss.[2]
Hair loss is not listed among the common side effects in the Ozempic or Mounjaro diabetes labels, where doses and weight loss are typically lower.
A 2026 systematic review of 24 studies reached a similar picture: semaglutide and tirzepatide had the highest reported rates among GLP-1 drugs, hair loss with semaglutide appeared dose-dependent, women seemed disproportionately affected, and rapid weight loss emerged as a likely contributor.[3]
Why GLP-1 drugs can cause hair loss: telogen effluvium
Each hair follicle cycles between a growing phase and a resting (telogen) phase. A significant stress to the body, such as surgery, illness, childbirth or a rapid drop in calories and weight, can push many follicles into the resting phase at once. A few months later, those hairs shed together. This is called telogen effluvium.[4]
The same pattern is well documented after bariatric surgery, where fast weight loss, low calorie and protein intake and micronutrient deficiencies are linked to telogen effluvium.[5] GLP-1 drugs can also produce large, fairly rapid weight loss, so a similar effect is plausible. The systematic review found telogen effluvium and androgenetic (pattern) hair loss were the subtypes most often reported, with tirzepatide most frequently linked to telogen effluvium.[3]
Whether the drugs also have a direct effect on hair follicles is not known. The labels frame hair loss as associated with weight reduction rather than a direct drug effect.[1][2]
When does it start and does it grow back?
Telogen effluvium typically shows up as diffuse shedding (more hair in the brush or shower drain) rather than bald patches, often a couple of months after the trigger. It usually settles once the trigger passes, and regrowth follows over months.[4]
For GLP-1 users, that means shedding may start a few months into treatment, when weight is falling fastest, and ease once weight stabilizes. There are no long-term trial data on regrowth specifically after GLP-1 hair loss, so if shedding continues for more than about six months, or you see patches, scalp redness or a widening part, see a doctor or dermatologist. Telogen effluvium can also unmask underlying pattern hair loss.[4]
How to reduce the risk of GLP-1 hair loss
No method has been tested in trials to prevent GLP-1 hair loss. These steps address the known triggers of telogen effluvium and are worth discussing with your clinician:
- Eat enough protein. A very small appetite can make protein intake drop sharply.
- Avoid extreme restriction. Do not stack a crash diet on top of the medication.
- Check for deficiencies. Ask about testing iron (ferritin), vitamin D, zinc and thyroid function, which can contribute to shedding.
- Do not escalate faster than prescribed. The labels use stepwise dosing; your clinician sets the pace.
- Be gentle with hair during shedding: avoid tight styles and harsh treatments.
Supplements such as biotin are often promoted for hair, but there is no evidence they prevent GLP-1-related shedding in people who are not deficient.
Questions to ask your clinician or dermatologist
- Does my shedding pattern look like telogen effluvium, or something else such as pattern hair loss or alopecia areata?
- Should I have blood tests for iron, thyroid function or vitamin levels?
- Is my weight coming off faster than planned, and should my dose escalation slow down?
- Am I eating enough protein on the days my appetite is very low?
- If shedding has not settled after several months, are there treatments worth trying?
Keep in mind that the trial figures describe how many people reported hair loss, not how severe it was. Most people in the trials did not report it at all.[1][2]
Hair loss and other changes from rapid weight loss
Hair shedding is one of several visible effects of fast weight loss. Facial volume loss is covered in our guide to Ozempic face, and gallbladder risk, which also rises with rapid weight loss, is covered in GLP-1s and the gallbladder. If side effects are piling up, our GLP-1 nausea guide covers how dose escalation affects tolerability.
This article is general information. Your clinician can help you weigh side effects against the benefits of treatment.
